Q1 EPS Estimates for Henry Schein Reduced by Zacks Research

Henry Schein, Inc. (NASDAQ:HSIC) – Research analysts at Zacks Research lowered their Q1 2027 earnings estimates for shares of Henry Schein in a report released on Tuesday, October 14th. Zacks Research analyst Team now anticipates that the company will post earnings of $1.38 per share for the quarter, down from their prior estimate of $1.39. The consensus estimate for Henry Schein’s current full-year earnings is $4.74 per share.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings data on Tuesday, August 5th. The company reported $1.10 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.19 by ($0.09). The company had revenue of $3.24 billion for the quarter, compared to analysts’ expectations of $3.22 billion. Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. The firm’s revenue for the quarter was up 3.3% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.23 earnings per share. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS.

A number of other analysts also recently weighed in on the stock. Evercore ISI raised shares of Henry Schein from an “in-line” rating to an “outperform” rating and set a $83.00 target price on the stock in a research report on Tuesday, August 26th. Baird R W downgraded shares of Henry Schein from a “strong-buy” rating to a “hold” rating in a research report on Monday, July 14th. Stifel Nicolaus reaffirmed a “hold” rating and issued a $75.00 target price (down from $80.00) on shares of Henry Schein in a research report on Friday, July 25th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Henry Schein in a research report on Wednesday, October 8th. Finally, JPMorgan Chase & Co. reduced their target price on shares of Henry Schein from $80.00 to $76.00 and set an “overweight” rating on the stock in a research report on Thursday, August 7th. Five equities research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $76.67.

Henry Schein Stock Up 1.5%

Shares of Henry Schein stock opened at $62.98 on Thursday. The company has a current ratio of 1.41, a quick ratio of 0.78 and a debt-to-equity ratio of 0.51. The company’s fifty day simple moving average is $67.12 and its two-hundred day simple moving average is $68.60. The company has a market cap of $7.64 billion, a P/E ratio of 20.32, a PEG ratio of 2.05 and a beta of 0.81. Henry Schein has a 12-month low of $60.56 and a 12-month high of $82.49.

Hedge Funds Weigh In On Henry Schein

Several hedge funds and other institutional investors have recently bought and sold shares of HSIC. Farther Finance Advisors LLC lifted its stake in Henry Schein by 237.3% during the 1st quarter. Farther Finance Advisors LLC now owns 2,698 shares of the company’s stock valued at $186,000 after acquiring an additional 1,898 shares during the period. GAMMA Investing LLC lifted its stake in Henry Schein by 37.8% during the 1st quarter. GAMMA Investing LLC now owns 3,939 shares of the company’s stock valued at $270,000 after acquiring an additional 1,081 shares during the period. Wealth Enhancement Advisory Services LLC lifted its stake in Henry Schein by 0.5% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 53,134 shares of the company’s stock valued at $3,639,000 after acquiring an additional 243 shares during the period. Exchange Traded Concepts LLC lifted its stake in Henry Schein by 18.5% during the 1st quarter. Exchange Traded Concepts LLC now owns 10,264 shares of the company’s stock valued at $703,000 after acquiring an additional 1,606 shares during the period. Finally, Cardinal Capital Management lifted its stake in Henry Schein by 3.3% during the 1st quarter. Cardinal Capital Management now owns 14,789 shares of the company’s stock valued at $1,013,000 after acquiring an additional 476 shares during the period. Institutional investors own 96.62% of the company’s stock.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.